About the journal
Antibody Therapeutics is an open-access journal published by Oxford University Press in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,687 USD. Declared review time at DOAJ: 8 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Oxford University Press
- ISSN
- 2516-4236
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,687 USD
- Articles in DOAJ
- 0
- Declared review time
- 8 weeks
- Declared peer-review model
- peer_review
- Official website
- https://academic.oup.com/abt
Index listings
- DOAJ · 2019-01-23
- Indexing
- DOAJ
- APC
- 2,687 USD
- Declared review time (DOAJ)
- 8 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
0
Average review time (journal-declared via DOAJ)
8weeks
Works in OpenAlex
283
Last recorded publication year
2026
h-index
33
i10-index
80
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2024-04-03
- Added to DOAJ
- 2019-01-23
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- Portico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 93%
- ORCID iDs in current deposits
- 84%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101730822
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- CAR-T cell therapy research
- CAR-T cell therapy research
- Protein purification and stability
- Protein purification and stability
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
Show all subjects (50)
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 and COVID-19 Research
- Glycosylation and Glycoproteins Research
- Glycosylation and Glycoproteins Research
- Immunotherapy and Immune Responses
- Viral Infectious Diseases and Gene Expression in Insects
- Viral Infectious Diseases and Gene Expression in Insects
- Immunotherapy and Immune Responses
- vaccines and immunoinformatics approaches
- vaccines and immunoinformatics approaches
- Transgenic Plants and Applications
- Transgenic Plants and Applications
- Cancer Immunotherapy and Biomarkers
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
- Biosimilars and Bioanalytical Methods
- Cancer Immunotherapy and Biomarkers
- Biosimilars and Bioanalytical Methods
- Advanced Biosensing Techniques and Applications
- Advanced Biosensing Techniques and Applications
- Toxin Mechanisms and Immunotoxins
- Toxin Mechanisms and Immunotoxins
- T-cell and B-cell Immunology
- T-cell and B-cell Immunology
- Phagocytosis and Immune Regulation
- Phagocytosis and Immune Regulation
- COVID-19 Clinical Research Studies
- COVID-19 Clinical Research Studies
- Biochemical and Structural Characterization
- Peptidase Inhibition and Analysis
- Biochemical and Structural Characterization
- Peptidase Inhibition and Analysis
- Bacteriophages and microbial interactions
- Bacteriophages and microbial interactions
- Radiopharmaceutical Chemistry and Applications
- Click Chemistry and Applications
- Click Chemistry and Applications
- Galectins and Cancer Biology
- Advanced Drug Delivery Systems
- Radiopharmaceutical Chemistry and Applications
- Galectins and Cancer Biology
- Nanoparticle-Based Drug Delivery
Keywords (DOAJ)
- therapeutics
- pharmacology
- antibodies
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ